We are live on ! Find out more
NSEDCP

NJ State Employees Deferred Compensation Plan Portfolio holdings

AUM $906M
1-Year Est. Return 24.85%
This Fund
S&P 500
This Quarter Est. Return
+10.32%
1 Year Est. Return
+24.85%
3 Year Est. Return
+127.22%
5 Year Est. Return
+201.43%
10 Year Est. Return
+564.84%
AUM
$618M
AUM Growth
+$34.4M
Cap. Flow
-$12M
Cap. Flow %
-1.95%
Top 10 Hldgs %
23.3%
Holding
492
New
15
Increased
–
Reduced
14
Closed
9

Top Buys

Rank Stock Value
1
APLS
Apellis Pharmaceuticals
APLS
+$318K
2
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$259K
3
MAN icon
ManpowerGroup
MAN
+$241K
4
UHS icon
Universal Health Services
UHS
+$236K
5
IR icon
Ingersoll Rand
IR
+$225K

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$3.1M
2
CTXS
Citrix Systems Inc
CTXS
+$2.08M
3
KLAC icon
KLA
KLAC
+$1.36M
4
ORCL icon
Oracle
ORCL
+$912K
5
ITW icon
Illinois Tool Works
ITW
+$745K

Sector Composition

Rank Sector Weight
1 Technology 23.28%
2 Healthcare 15.2%
3 Financials 13.94%
4 Industrials 12.19%
5 Consumer Discretionary 7.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TREX icon
301
Trex
TREX
$5.05B
$423K 0.07%
10,000
– –
INDB icon
302
Independent Bank
INDB
$4.08B
$422K 0.07%
5,000
– –
LEGN icon
303
Legend Biotech
LEGN
$3.69B
$414K 0.07%
8,300
– –
CADE
304
DELISTED
Cadence Bank
CADE
$414K 0.07%
16,800
– –
BHF icon
305
Brighthouse Financial
BHF
$3.55B
$414K 0.07%
8,069
– –
MO icon
306
Altria Group
MO
$114B
$411K 0.07%
9,000
– –
ONB icon
307
Old National Bancorp
ONB
$10.3B
$408K 0.07%
22,672
– –
AVGO icon
308
Broadcom
AVGO
$1.99T
$406K 0.07%
7,270
– –
ILMN icon
309
Illumina
ILMN
$30.2B
$404K 0.07%
2,056
– –
CHGG icon
310
Chegg
CHGG
$115M
$404K 0.07%
16,000
– –
REVG
311
DELISTED
REV Group
REVG
$404K 0.07%
32,000
– –
ACA icon
312
Arcosa
ACA
$7.14B
$402K 0.07%
7,400
– –
THR
313
DELISTED
Thermon Group Holdings
THR
$402K 0.07%
20,000
– –
CMCO icon
314
Columbus McKinnon
CMCO
$621M
$390K 0.06%
12,000
– –
COHR icon
315
Coherent
COHR
$64.2B
$386K 0.06%
10,988
– –
EGP icon
316
EastGroup Properties
EGP
$10.9B
$385K 0.06%
2,600
– –
HOPE icon
317
Hope Bancorp
HOPE
$1.82B
$384K 0.06%
30,000
– –
SSB icon
318
SouthState Bank Corp
SSB
$10.6B
$382K 0.06%
5,000
– –
HE icon
319
Hawaiian Electric Industries
HE
$2.17B
$377K 0.06%
9,000
– –
TRN icon
320
Trinity Industries
TRN
$2.59B
$376K 0.06%
12,700
-17,300
-58% -$482K
DY icon
321
Dycom Industries
DY
$12.3B
$374K 0.06%
4,000
– –
SYK icon
322
Stryker
SYK
$129B
$367K 0.06%
1,500
– –
KOP icon
323
Koppers
KOP
$981M
$367K 0.06%
13,000
– –
KMX icon
324
CarMax
KMX
$8.04B
$365K 0.06%
6,000
– –
C icon
325
Citigroup
C
$231B
$362K 0.06%
8,000
– –
11 12
13
14 15

Similar funds

IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
BFS
Bard Financial Services Branford, Connecticut $911M AUM 19.14% 1-Year Est. Return
MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return
SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return
CP
Coho Partners Berwyn, Pennsylvania $779M AUM 4.46% 1-Year Est. Return
EAM
EFG Asset Management Portland, Oregon $773M AUM 40.1% 1-Year Est. Return
HWM
Hemington Wealth Management Falls Church, Virginia $769M AUM 13.16% 1-Year Est. Return
BVDMP
Bedrijfstakpensioenfonds Voor De Media PNO Hilversum, Netherlands $759M AUM 19.37% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's Q4 2022 Portfolio in Review

As of Q4 2022, NJ State Employees Deferred Compensation Plan held 492 positions worth $618M, up 5.9% from $584M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q4 2022: portfolio turnover was 4.9%. NJ State Employees Deferred Compensation Plan opened 15 new positions and exited 9, leaving the 492-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

  • NJ State Employees Deferred Compensation Plan's largest Q4 2022 buy was Apellis Pharmaceuticals: 6,000 shares worth $310K.
  • NJ State Employees Deferred Compensation Plan's biggest Q4 2022 reduction was KLA, cutting an estimated $1.36M.
  • NJ State Employees Deferred Compensation Plan fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $3.1M.
  • NJ State Employees Deferred Compensation Plan's ten largest holdings make up 23% of its $618M portfolio in Q4 2022.
  • NJ State Employees Deferred Compensation Plan opened 15 new positions and closed 9 in Q4 2022.
  • NJ State Employees Deferred Compensation Plan's portfolio value rose 5.9% quarter-over-quarter to $618M.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q4 2022, filed 26 Jan 2023.